Moreover, the correlation between IGF1/IGFBP3 and severity of NAFLD retains significance, after adjustment for age, gender, race/ethnicity, homeostasis model assessment for insulin resistance (HOMA-IR) and adiposity [112]. This evidence concerns the gene IGFBP3 and metabolic dysfunction-associated steatotic liver disease.